| Year |
Citation |
Score |
| 2024 |
Park S, Bang SY, Kwag D, Lee JH, Kim TY, Lee J, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, et al. Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone Marrow Transplantation. PMID 38438648 DOI: 10.1038/s41409-024-02255-w |
0.393 |
|
| 2023 |
Lee JY, Park SS, Jeon YW, Shin SH, Yahng SA, Min CK. Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study. Journal of Cancer Research and Clinical Oncology. PMID 37418057 DOI: 10.1007/s00432-023-04993-8 |
0.347 |
|
| 2022 |
Park S, Kwag D, Kim TY, Lee JH, Lee JY, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, et al. A retrospective comparison of salvage intensive chemotherapy venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML). Therapeutic Advances in Hematology. 13: 20406207221081637. PMID 35340720 DOI: 10.1177/20406207221081637 |
0.396 |
|
| 2021 |
Park S, Kim TY, Lee JH, Lee JY, Min GJ, Park SS, Yahng SA, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Lee S, Kim HJ, Min CK, et al. Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome. Therapeutic Advances in Hematology. 12: 20406207211043748. PMID 34589195 DOI: 10.1177/20406207211043748 |
0.452 |
|
| 2021 |
Cho BS, Min GJ, Park SS, Yoon SY, Park S, Jeon YW, Shin SH, Yahng SA, Yoon JH, Lee SE, Eom KS, Kim YJ, Min CK, Cho SG, Kim DW, et al. Low-dose Thymoglobulin for prevention of chronic graft-versus-host disease in transplantation from an HLA-matched sibling donor. American Journal of Hematology. PMID 34390504 DOI: 10.1002/ajh.26320 |
0.319 |
|
| 2021 |
Cho BS, Min GJ, Park SS, Park S, Jeon YW, Shin SH, Yahng SA, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11. Bone Marrow Transplantation. PMID 34183780 DOI: 10.1038/s41409-021-01384-w |
0.357 |
|
| 2021 |
Cho BS, Yahng SA, Min GJ, Park S, Park SS, Shin SH, Jeon YW, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual disease for acute myeloid leukemia in elderly patients. Transplantation and Cellular Therapy. PMID 34082159 DOI: 10.1016/j.jtct.2021.05.024 |
0.419 |
|
| 2021 |
Cho BS, Min GJ, Park SS, Park S, Jeon YW, Shin SH, Yahng SA, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Prognostic Impacts of D816V Mutation and Peri-Transplant MRD Monitoring on Acute Myeloid Leukemia with . Cancers. 13. PMID 33477584 DOI: 10.3390/cancers13020336 |
0.341 |
|
| 2020 |
Cho BS, Min GJ, Park S, Park SS, Shin SH, Yahng SA, Jeon YW, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Haploidentical versus matched unrelated donor transplantation for acute myeloid leukemia in remission: a prospective comparative study. American Journal of Hematology. PMID 32905642 DOI: 10.1002/ajh.25993 |
0.418 |
|
| 2020 |
Park S, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Comparison of myeloablative (CyTBI, BuCy) versus reduced-intensity (FluBu2TBI400) peripheral blood stem cell transplantation in acute myeloid leukemia patients with pre-transplant low WT1 expression. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32659434 DOI: 10.1016/j.bbmt.2020.07.006 |
0.479 |
|
| 2020 |
Shin SH, Park SS, Park S, Jeon YW, Yoon JH, Yahng SA, Cho BS, Kim YJ, Lee S, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Eom KS. Nonmyeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies. European Journal of Haematology. PMID 32470197 DOI: 10.1111/ejh.13455 |
0.307 |
|
| 2020 |
Yahng SA, Min GJ, Park SS, Park S, Jeon YW, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Lee S, Min CK, Kim HJ, Lee JW, Kim YJ. Role of pre-transplant anti-thymocyte globulin in matched sibling donor- stem cell transplantation after reduced intensity conditioning for MDS. European Journal of Haematology. PMID 31957068 DOI: 10.1111/ejh.13386 |
0.337 |
|
| 2019 |
Cho BS, Min GJ, Park SS, Shin SH, Yahng SA, Jeon YW, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, et al. WT1 measurable residual disease assay in AML who underwent allogeneic hematopoietic stem cell transplantation; optimal time points, threshold, and candidates. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31173897 DOI: 10.1016/j.bbmt.2019.05.033 |
0.394 |
|
| 2018 |
Kim TW, Park SS, Lim JY, Min GJ, Park S, Jeon YW, Yahng SA, Shin SH, Lee SE, Yoon JH, Cho BS, Eom KS, Lee S, Kim HJ, Min CK. Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia. International Journal of Stem Cells. PMID 30595008 DOI: 10.15283/ijsc18094 |
0.368 |
|
| 2018 |
Park SS, Jeon YW, Min GJ, Park S, Yahng SA, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Lee S, Kim HJ, Min CK, Cho SG, Lee JW, et al. Graft-versus-host disease free, relapse-free survival after allogeneic stem cell transplantation for myelodysplastic syndrome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30103018 DOI: 10.1016/j.bbmt.2018.08.004 |
0.323 |
|
| 2018 |
Shin SH, Jeon YW, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Lee S, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Kim YJ. Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome. European Journal of Haematology. PMID 29758108 DOI: 10.1111/ejh.13095 |
0.349 |
|
| 2018 |
Yahng SA, Park SS, Jeon YW, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Kim DW, Min WS, et al. Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia. Bone Marrow Transplantation. PMID 29563590 DOI: 10.1038/s41409-018-0154-0 |
0.373 |
|
| 2018 |
Park SS, Kim HJ, Min KI, Min GJ, Jeon YW, Yoon JH, Yahng SA, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, et al. Prognostic Prediction Model for Second Allogeneic Stem-Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single-Center Report. Clinical Lymphoma, Myeloma & Leukemia. PMID 29519618 DOI: 10.1016/j.clml.2018.02.009 |
0.375 |
|
| 2017 |
Shin S, Dorfman KD, Cheng X. Shear-banding and superdiffusivity in entangled polymer solutions. Physical Review. E. 96: 062503. PMID 29347293 DOI: 10.1103/Physreve.96.062503 |
0.335 |
|
| 2016 |
Yahng SA, Kim M, Kim TM, Jeon YW, Yoon JH, Shin SH, Lee SE, Eom KS, Lee S, Min CK, Kim HJ, Kim DW, Lee JW, Min WS, Kim YJ. Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts. Oncotarget. PMID 27729615 DOI: 10.18632/oncotarget.12511 |
0.41 |
|
| 2015 |
Yahng SA, Jeon YW, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Kim HJ. Negative impact of unidirectional host-versus-graft KIR-ligand mismatch on transplant outcomes following unmanipulated haploidentical peripheral blood stem cell transplantation for acute myeloid leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26415557 DOI: 10.1016/j.bbmt.2015.09.018 |
0.308 |
|
| 2015 |
Yoon JH, Jeon YW, Yahng SA, Shin SH, Lee SE, Cho BS, Lee DG, Eom KS, Kim HJ, Lee S, Min CK, Cho SG, Kim Y, Kim DW, Lee JW, et al. Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 460-7. PMID 25460359 DOI: 10.1016/j.bbmt.2014.11.008 |
0.397 |
|
| 2015 |
Shin SH, Kim JH, Jeon YW, Yoon JH, Yahng SA, Lee SE, Choi YS, Kim DY, Lee JH, Lee S, Kim HJ, Min CK, Lee JW, Lee KH, Min WS, et al. Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 342-9. PMID 25459640 DOI: 10.1016/j.bbmt.2014.10.031 |
0.375 |
|
| 2015 |
Eom KS, Kim HJ, Cho BS, Lee SE, Yahng SA, Yoon JH, Shin SH, Jeon YW, Kim JH, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, et al. Equivalent outcome of autologous stem cell transplantation and reduced intensity conditioning stem cell transplantation in acute myeloid leukemia patients with t(8;21). Acta Haematologica. 133: 266-76. PMID 25413265 DOI: 10.1159/000366261 |
0.317 |
|
| 2015 |
Yahng SA, Kim JH, Jeon YW, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, et al. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 119-29. PMID 25300871 DOI: 10.1016/j.bbmt.2014.09.029 |
0.374 |
|
| 2015 |
Lee SE, Kim JH, Jeon YW, Yoon JH, Shin SH, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Lee JW, Min WS, Park CW, Min CK. Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma. Annals of Hematology. 94: 445-52. PMID 25257340 DOI: 10.1007/s00277-014-2216-8 |
0.387 |
|
| 2014 |
Shin SH, Kim JH, Jeon YW, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, et al. Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxis. European Journal of Haematology. 93: 19-28. PMID 24527665 DOI: 10.1111/ejh.12287 |
0.388 |
|
| 2014 |
Yahng SA, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Park CW, Kim Y, et al. Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphoma. British Journal of Haematology. 164: 555-64. PMID 24266323 DOI: 10.1111/bjh.12664 |
0.337 |
|
| 2014 |
Yoon JH, Kim HJ, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation? Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 80-8. PMID 24149098 DOI: 10.1016/j.bbmt.2013.10.015 |
0.374 |
|
| 2014 |
Lee SE, Yoon JH, Shin SH, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Min CK. Impact of failed response to novel agent induction in autologous stem cell transplantation for multiple myeloma. Annals of Hematology. 93: 627-34. PMID 24085241 DOI: 10.1007/s00277-013-1911-1 |
0.316 |
|
| 2013 |
Lee SE, Yoon JH, Shin SH, Park G, Min CK. Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma. Immune Network. 13: 107-10. PMID 23885225 DOI: 10.4110/in.2013.13.3.107 |
0.353 |
|
| 2013 |
Yahng SA, Yoon JH, Shin SH, Lee SE, Eom KS, Kim YJ. Acute colonic pseudo-obstruction following allogeneic stem cell transplantation successfully treated by neostigmine. Blood Research. 48: 145-8. PMID 23826585 DOI: 10.5045/br.2013.48.2.145 |
0.356 |
|
| 2013 |
Yoon JH, Kim HJ, Shin SH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, et al. BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML. European Journal of Haematology. 91: 112-21. PMID 23672350 DOI: 10.1111/ejh.12142 |
0.311 |
|
| 2013 |
Eom KS, Shin SH, Yoon JH, Yahng SA, Lee SE, Cho BS, Kim YJ, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Park CW, Lee S. Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission. American Journal of Hematology. 88: 634-41. PMID 23620000 DOI: 10.1002/ajh.23465 |
0.385 |
|
| 2013 |
Yoon JH, Kim HJ, Shin SH, Yahng SA, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW. Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation. International Journal of Hematology. 97: 773-81. PMID 23616221 DOI: 10.1007/s12185-013-1335-7 |
0.398 |
|
| 2013 |
Yoon JH, Kim HJ, Shin SH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, et al. Serial measurement of WT1 expression and decrement ratio until hematopoietic cell transplantation as a marker of residual disease in patients with cytogenetically normal acute myelogenous leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 958-66. PMID 23542687 DOI: 10.1016/j.bbmt.2013.03.013 |
0.356 |
|
| 2013 |
Lee SE, Yoon JH, Shin SH, Yahng SA, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim M, et al. Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia. International Journal of Hematology. 97: 640-9. PMID 23529846 DOI: 10.1007/s12185-013-1312-1 |
0.429 |
|
| 2013 |
Cho BS, Kim JH, Yoon JH, Shin SH, Yahng SA, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, et al. Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission. European Journal of Haematology. 90: 365-74. PMID 23414524 DOI: 10.1111/ejh.12089 |
0.393 |
|
| 2012 |
Cho BS, Yoon JH, Shin SH, Yahng SA, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim HJ. Comparison of allogeneic stem cell transplantation from familial-mismatched/haploidentical donors and from unrelated donors in adults with high-risk acute myelogenous leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1552-63. PMID 22516055 DOI: 10.1016/j.bbmt.2012.04.008 |
0.434 |
|
| Show low-probability matches. |